Phase I and Pharmacokinetic Study of Gemcitabine Administered at Fixed-Dose Rate, Combined with Docetaxel/Melphalan/Carboplatin, with Autologous Hematopoietic Progenitor-Cell Support, in Patients with Advanced Refractory Tumors
Titel:
Phase I and Pharmacokinetic Study of Gemcitabine Administered at Fixed-Dose Rate, Combined with Docetaxel/Melphalan/Carboplatin, with Autologous Hematopoietic Progenitor-Cell Support, in Patients with Advanced Refractory Tumors
Auteur:
Nieto, Yago Aldaz, Azucena Rifón, José Pérez-Calvo, Javier Zafra, Ana Zufia, Laura Viúdez, Antonio Viteri, Santiago Aramendía, José Manuel Aristu, Javier Centeno, Carlos Moreno, Marta Sayar, Onintza Hernández, Milagros
Verschenen in:
Biology of blood and marrow transplantation
Paginering:
Jaargang 13 (2007) nr. 11 pagina's 14 p.
Jaar:
2007
Inhoud:
Uitgever:
American Society for Blood and Marrow Transplantation